文献速递前列腺癌

阴茎癌保留器官整形重建手术的肿瘤学与功能结局

Oncological and Functional Outcomes After Organ-Sparing Plastic Reconstructive Surgery for Penile Cancer.
PubMed 文献 · Urology · 2020-05-05

多中心研究纳入57例阴茎鳞状细胞癌患者,接受保留器官手术联合全厚皮片移植重建。中位随访55.7个月,5年生存率87.5%,5年无进展生存率83%;32例功能评估显示健康状态82.5%、排尿症状中位评分4、IIEF-5中位19,结论为选择性病例中安全可行。

要点

  • 保留器官整形重建手术在选择性阴茎鳞癌病例中肿瘤学安全可行
  • 术后排尿与性功能及健康相关生活质量保持良好
  • 需长期随访监测肿瘤进展与复发

核心结论

  • 在选择性病例中,阴茎保留器官手术联合整形重建是治疗鳞状细胞癌的安全可行选择,不损害肿瘤学安全性。

研究设计与样本

  • 多中心研究报告2007至2019年57例阴茎恶性病变患者接受保留器官手术联合全厚皮片移植重建的临床病理数据。

主要发现

  • 中位年龄55.1岁(IQR 29-90),中位随访55.7个月(3-149)。
  • 6例(12.5%)死于鳞状细胞癌,10例(17.8%)出现进展。
  • Kaplan-Meier估计5年生存率87.5%,5年无进展生存率83%。
  • 32例评估中,EuroQoL-5D-3L平均健康状态82.5%,ICIQ-MLTUS排尿评分中位4(IQR 1-15),IIEF-5中位19(IQR 10.75-25)。

临床怎么用

  • 对选择性阴茎鳞癌患者,可考虑保留器官整形重建手术以维持排尿和性功能及生活质量。

局限性

  • 功能结局仅在32例中评估,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe oncological and functional outcomes in patients treated with reconstructive organ-sparing surgery (OSS) for squamous cell carcinoma of the penis. Plastic reconstructive OSS of the penis with a split thickness skin graft has been proposed as a treatment option for penile cancer, with the objective being preservation of physiological voiding and sexual function without comprising oncological control. MATERIALS AND METHODS: Multicenter study reporting clinicopathological data of 57 patients with malignant lesions of the penis treated with OSS and plastic reconstructive surgery with split thickness skin graft from 2007 to 2019. Health related quality of life (HRQoL) was assessed with EuroQoL-5D-3L, urinary symptoms with the International Consultation on Incontinence Modular Questionnaire for Male Lower Urinary Tract Symptoms, and erectile function with the International Index of erectile function (IIEF)-5. RESULTS: Fifty-seven patients underwent OSS reconstructive surgery. Twenty underwent glans resurfacing, 23 partial penectomy, and 14 glansectomy. Median age was 55.1 years (interquartile range [IQR] 29-90), median follow-up 55.7 months (3-149). At the time of data analysis, 6 patients had died of Squamous Cell Carcinoma (SCC) (12.5%) and 10 (17.8%) had progressed. Kaplan-Meier estimates showed a 5-year survival rate of 87.5% and a 5-year progression-free survival of 83%. We assessed HRQoL and functional outcomes in 32 patients. EuroQol 5D-3L showed a mean health status of 82.5%, median Voiding score of the ICIQ-MLTUS was 4 (IQR 1-15), and median IIEF-5 19 (IQR 10.75-25). CONCLUSION: OSS of the penis remains a safe and viable option for the treatment of SCC, ensuring a favorable appearance of the penis, preserving urinary and sexual function, with good HRQoL and without comprising oncological safety in selected cases.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Pérez J, Chavarriaga J, Ortiz A, et al. Oncological and Functional Outcomes After Organ-Sparing Plastic Reconstructive Surgery for Penile Cancer. Urology. 2020. PMID: 32380155. doi:10.1016/j.urology.2020.03.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。